Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
PT Diagnos Laboratorium Utama Tbk
DGNS
Sector: Healthcare
Industry: Healthcare Providers
Sub Sector: Healthcare Equipment & Providers
Sub Industry: Healthcare Providers
Live quote
tidak tersedia
Highlight Keuangan (2026 Q2) (In Rp)
EPS
-4
ROE
-2,63%
ROA
-1,78%
Book Value
167
Net Income
-3,02 M
Total Sales
86,75 M
Total Assets
339,37 M
DER
0.47x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
22,97%
PT BUNDAMEDIK 🔗
37,45%
Corporate · Lokal
PT. BUNDA INVESTAMA INDONESIA 🔗
32,57%
Private Equity · Lokal
MULTI GARAM UTAMA TBK PT 🔗
7,01%
Corporate · Lokal
Tentang Perusahaan
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Produk & Lini Bisnis
The Company’s scope of activities is engaged in providing health support services, such as health laboratories, other diagnostic drawing centers, blood testing laboratories, pharmaceutical warehouse, eye banks, sperm bank and blood banks, organ transplant banks and other medical support services.
Dewan Direksi
IM
Ir. Mesha Rizal Sini
President Director
RR
Renobulan Rizal Sini Suheimi
Director
FR
Fergus Richard
Director
DD
Dilly Dwiasri
Director
Dewan Komisaris
IR
Ivan Rizal Sini
President Commissioner
AH
Agus Heru Darjono
Commissioner
ME
Martinus Eliatulo Zega
Independent Commissioner
Anak Usaha & Afiliasi
NamaDomisili%
 %
Trend Keuangan (5 periode terakhir) — hover bar untuk detail
Total Sales Net Income (+) Net Income (-)
167jt 125jt 83jt 42jt 0 Sales 2025Q2: Rp 76.883.349 Net Income 2025Q2: Rp -2.128.768 2025Q2 Sales 2025Q3: Rp 118.274.284 Net Income 2025Q3: Rp -2.650.393 2025Q3 Sales 2025Q4: Rp 166.623.564 Net Income 2025Q4: Rp 2.937.095 2025Q4 Sales 2026Q1: Rp 41.632.491 Net Income 2026Q1: Rp -1.316.147 2026Q1 Sales 2026Q2: Rp 86.745.499 Net Income 2026Q2: Rp -3.022.343 2026Q2
2025 Q2
EPS -3
ROE -2,19%
2025 Q3
EPS -3
ROE -1,83%
2025 Q4
EPS 2
ROE 1,44%
2026 Q1
EPS -4
ROE -2,60%
2026 Q2
EPS -4
ROE -2,63%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
PeriodeTotal SalesNet IncomeTotal AssetsTotal EquityEPSROEDER
2026 Q2 86,75 M -3,02 M 339,37 M 230,22 M -4 -2,63% 0.47x
2026 Q1 41,63 M -1,32 M 318,73 M 202,67 M -4 -2,60% 0.57x
2025 Q4 166,62 M 2,94 M 318,67 M 203,99 M 2 1,44% 0.56x
2025 Q3 118,27 M -2,65 M 305,64 M 193,48 M -3 -1,83% 0.58x
2025 Q2 76,88 M -2,13 M 304,08 M 194,00 M -3 -2,19% 0.57x
Trend Harga Penutupan & Book Value — hover titik untuk detail
Close Price Book Value
318 273 227 182 137 Book Value 2025Q2: Rp 155 Close 2025Q2: Rp 154 2025Q2 Book Value 2025Q3: Rp 155 Close 2025Q3: Rp 145 2025Q3 Book Value 2025Q4: Rp 163 Close 2025Q4: Rp 184 2025Q4 Book Value 2026Q1: Rp 162 Close 2026Q1: Rp 302 2026Q1 Book Value 2026Q2: Rp 167 Close 2026Q2: Rp 226 2026Q2
2025 Q2
Close 154
BV 155
ROA -1,40%
2025 Q3
Close 145
BV 155
ROA -1,16%
2025 Q4
Close 184
BV 163
ROA 0,92%
2026 Q1
Close 302
BV 162
ROA -1,65%
2026 Q2
Close 226
BV 167
ROA -1,78%
History Harga Penutupan & Book Value
TahunQrtClose Price (Rp)Book Value (Rp)ROA
2026 2 226 167 -1,78%
2026 1 302 162 -1,65%
2025 4 184 163 0,92%
2025 3 145 155 -1,16%
2025 2 154 155 -1,40%
Data diperbarui pada: 2026-05-12 10:15:43